Green Giants Third Quarter 2022 Newsletter
These are tough times for all investors and few are having it worse than the cannabis community. It’s been a humbling 600-day period. We are in an 80% drawdown in an illiquid sector that few investors care about.
Green Giants June 2022 Newletter
June marked the end of a brutal first half of the year. The S&P 500 finished down -20.6%, its worst start since 1970 and the MSCI World Index return of -20.9% was the worst first-half in its history. Inflation and slowing growth are taking their toll on all risk assets.
Green Giants May 2022 Newsletter
During May broad US indexes finished about flat and cannabis stocks posted another negative month. The US cannabis markets have lost money in 14/15 months and are in the midst of a 75% drawdown. There is no way to sugarcoat it: this is a painful period.
Green Giants April 2022 Newsletter
The S&P 500 is off to its worst start since 1939, and the NASDAQ notched its worst opening quarter since launching in 1971. For cannabis stocks, it was the worst month since COVID-lows of March 2020.
Green Giants March 2022 Newsletter
What we have largely experienced are delays, rather than cracks in the fundamental story. I remain positive and believe the Green Giants strategy of focusing on the most-dominant operators is the least-risky means of capitalzing on the eventual opportunity.
Green Giants February 2022 Newsletter
In another volatile period, the Green Giants model portfolio earned its first positive month since we started trading on October 1st, 2021. Year-to-date, we are comfortably ahead of our cannabis-investing peers.
Green Giants January 2022 Newsletter
If cannabis stocks made a New Year’s resolution to perform better, it lasted two weeks. Through January 17th, the Green Giants model portfolio was positive. This changed when inflation fears surged, all equities collapsed, and cannabis stocks sold off in sympathy.
Green Giants December 2021 Newsletter
Benjamin Graham said, “In the short run, the market is a voting machine, but in the long run it is a weighing machine.” We are in a period where cannabis companies’ successes are not being recognized. While frustrating, this presents ideal conditions for accumulating assets and building portfolios.
Green Giants November 2021 Newsletter
November was a wild month for cannabis stocks. Despite pockets of optimism, we closed with back-to-back brutal days and ended down -4.94% for the month. Misery loves company, and the MSOS ETF, American Cannabis Operators Index and Russell 2000 all suffered as well.
Green Giants October 2021 Newsletter
October was another brutal month for cannabis stocks. We entered October in a 8-month post-election free fall and I hoped we might catch a bounce in our first month of trading the Green Giants strategy. We were not so fortunate.